BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 23653967)

  • 1. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
    Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
    J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
    Caballero T; Farkas H; Bouillet L; Bowen T; Gompel A; Fagerberg C; Bjökander J; Bork K; Bygum A; Cicardi M; de Carolis C; Frank M; Gooi JH; Longhurst H; Martínez-Saguer I; Nielsen EW; Obtulowitz K; Perricone R; Prior N;
    J Allergy Clin Immunol; 2012 Feb; 129(2):308-20. PubMed ID: 22197274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
    Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
    J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey.
    Farkas H; Zotter Z; Csuka D; Szabó E; Nébenfűhrer Z; Temesszentandrási G; Jakab L; Varga L; Harmat G; Karádi I
    Allergy; 2012 Dec; 67(12):1586-93. PubMed ID: 23025435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
    Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
    Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
    Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
    Moellman JJ; Bernstein JA
    J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review.
    Bork K; Steffensen I; Machnig T
    Allergy Asthma Proc; 2013; 34(4):312-327. PubMed ID: 23710659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
    Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
    Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioedema: an update on available therapeutic options.
    Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):663-72. PubMed ID: 20602665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
    Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.